BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guarascio AJ, Bhanot N, Min Z. Voriconazole-associated periostitis: Pathophysiology, risk factors, clinical manifestations, diagnosis, and management. World J Transplant 2021; 11(9): 356-371 [PMID: 34631468 DOI: 10.5500/wjt.v11.i9.356]
URL: https://www.wjgnet.com/2220-3230/full/v11/i9/356.htm
Number Citing Articles
1
Tristan D Cooper-Roth, Caleb R Boehler, Stefano J Natali, Sami R Ahmed, Tyson S Chadaz. Voriconazole-Induced Periostitis: A Case Report Cureus 2023;  doi: 10.7759/cureus.45947
2
Simona Stefan, Nadera Altork, Yazan Alzedaneen, Hilary Whitlatch, Kashif M. Munir. Voriconazole-Induced Diffuse PeriostitisAACE Clinical Case Reports 2022; 8(5): 191 doi: 10.1016/j.aace.2022.05.001
3
Myriam Mellou, Bénédicte Lelièvre, Delphine Bourneau-Martin, Christine Le Beller, Véronique Pizzoglio, Gwenaelle Veyrac, Joelle Michot, François Parant, Marie Briet. Drug-induced fluorosis: A study based on the national and international pharmacovigilance databasesTherapies 2025;  doi: 10.1016/j.therap.2025.06.006
4
Gouji Toyokawa, Miho Yamaguchi, Takafumi Yamaya, Mitsuaki Kawashima, Chihiro Konoeda, Koh Okamoto, Masaaki Sato. Voriconazole-induced Periostitis Following Lung Transplantation: Case SeriesTransplantation Reports 2025; 10(3): 100179 doi: 10.1016/j.tpr.2025.100179
5
Esther Ebstein, Valérie Bousson. L'actualité Rhumatologique 2023-20242023; : 61 doi: 10.1016/B978-2-294-78249-7.00008-4
6
Chris Newman, Henry Knipe, Rohit Sharma. Radiopaedia.org2022;  doi: 10.53347/rID-147153
7
Gurbinder Singh, Daria Motamedi, Kevin Sweetwood. Voriconazole-induced periostitis in the handRadiology Case Reports 2025; 20(3): 1431 doi: 10.1016/j.radcr.2024.11.079
8
Kathryn Barros, John William Tepper, Juhi Ramchandani, Meagan Kristine Kelley, Michelle L. Kussin, Emily N. Israel, Madeline G. Tompkins, Muayad Alali. Unusual presentation of disseminated cryptococcal infection complicated by myocarditis in a heart transplant recipientPediatric Transplantation 2024; 28(1) doi: 10.1111/petr.14585
9
Matthew I. Balcerek, Adam G. Stewart, Paul Chapman, Syndia Lazarus. Reducing the off-target endocrinologic adverse effects of azole antifungals—can it be done?International Journal of Antimicrobial Agents 2022; 59(5): 106587 doi: 10.1016/j.ijantimicag.2022.106587
10
Hailong Li, Miao Zhang, Xuefeng Jiao, Yu Zhu, Yan Liu, Linan Zeng, Huiqing Wang, Lei Zhang, Wei Zhang, Lingli Zhang. Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA Adverse Event Reporting System DatabaseScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-27687-0
11
Adrian Mark Masnammany, Wendy Lau, Peter Kee Kee Wong, Nicholas Manolios. Voriconazole-induced arthritis, enthesitis and periostitisProceedings of Singapore Healthcare 2023; 32 doi: 10.1177/20101058221149575
12
Chris Newman. Radiopaedia.org2022;  doi: 10.53347/rID-98847
13
Walid Ashmeik, Silvia Schirò, Gabby B. Joseph, Thomas M. Link. Associations of cumulative voriconazole dose, treatment duration, and alkaline phosphatase with voriconazole-induced periostitisSkeletal Radiology 2025; 54(1): 41 doi: 10.1007/s00256-024-04707-2